Concepedia

Sophie Langouët

SL

60

Publications

3.8K

Citations

34

H-Index

1993

Active since

Affiliations

Inserm(Current)

Université de Rennes

Institut de Recherche en Santé, Environnement et Travail

Structure Fédérative de Recherche en Biologie et Santé de Rennes

Vanderbilt University

Sophie Langouët is an author at Inserm specializing in medicine, pharmacology, and liver physiology.

ORCID

Top concepts

Publications per year

1993–2023

60

Publications

60

EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS

Caroline Aninat, Amélie Piton, Denise Glaise et al. · Drug Metabolism and Disposition · 2005 · 669 citations

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.

Laurence Berthou, Nicolas Duverger, F. Emmanuel et al. · Journal of Clinical Investigation · 1996 · 250 citations · Full text

, , +26

Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes.

Karine Mahéo, Franck Morel, Sophie Langouët et al. · PubMed · 1997 · 231 citations

Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.

Sophie Langouët, B Coles, Franck Morel et al. · PubMed · 1995 · 154 citations

, , +21

Inhibition of Human Cytochrome P450 Enzymes by 1,2-Dithiole-3-thione, Oltipraz and Its Derivatives, and Sulforaphane

Sophie Langouët, Laura Lowe Furge, Nathalie Kerriguy et al. · Chemical Research in Toxicology · 2000 · 116 citations

Rows per page

1–5 of 60